Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.

Join

Subscribe or Register

Existing user? Login

Spotlight on medicines: Denosumab

By Wasim Baqir, PhD, MRPharmS, and Carmel Copeland, DipClinPharm, MRPharmS

Osteoporotic boneDenosumab is the first in a new class of medicines for the treatment of osteoporosis. But, considering that there are other well established treatment options, what is denosumab’s place in therapy?

 

Verdict

The treatment options for osteoporosis in patients who are not able to tolerate or comply with administration instructions for bisphosphonates are limited.

Denosumab is a novel agent that offers a cost-effective alternative to bisphosphonates for the treatment of osteoporosis in postmenopausal women.

 

Full text article available to read as a PDF (900K) file.

Wasim Baqir and Carmel Copeland are senior clinical pharmacists at Northumbria Healthcare NHS Foundation Trust.

Email: wasim.baqir@nhs.net

Contribute to "Spotlight on medicines"

This Clinical Pharmacist series looks at prominent or recently launched medicines or classes of drugs. Comments on this or other articles are welcomed in the form of personal feedback to the editor or correspondence to Clinical Pharmacist.

Pharmacists who have ideas for the series or wish to write about medicines are invited to contact the editor.

Email: clinicalpharmacist@pharmj.org.uk

Tel: +44 (0)20 7572 2425

Citation: Clinical Pharmacist URI: 11049427

Have your say

For commenting, please login or register as a user and agree to our Community Guidelines. You will be re-directed back to this page where you will have the ability to comment.

Recommended from Pharmaceutical Press

  • BNF and BNF for Children

    BNF and BNF for Children

    Now available as a 1 year print subscription to both the BNF and BNFC, ensuring you have the latest medicines information as it publishes and at a greatly reduced price.

    £138.50Buy now
  • BNF and BNF for Children

    BNF and BNF for Children

    Now available as a 2 year print subscription to both the BNF and BNFC, ensuring you have the latest medicines information as it publishes and at a greatly reduced price.

    £262.50Buy now
  • Pharmaceutical Toxicology

    Pharmaceutical Toxicology

    Explains the methodology and requirements of pre-clinical safety assessments of new medicines. Includes registration requirements and pharmacovigilance.

    £40.00Buy now
  • Strategic Medicines Management

    Strategic Medicines Management

    A practical guide to influencing the availability of medicines, and policies of their use. Focuses on the strategic elements of medicines management.

    £33.00Buy now
  • Introduction to Clinical Pharmaceutics (An)

    Introduction to Clinical Pharmaceutics (An)

    This unique textbook covers the role of basic pharmaceutics in clinical outcomes and in explaining the behaviour of medicines in the body.

    £27.00Buy now

Search an extensive range of the world’s most trusted resources

Powered by MedicinesComplete
  • Print
  • Share
  • Comment
  • Save
  • Print Friendly Version of this pagePrint Get a PDF version of this webpagePDF

Supplementary information

Jobs you might like

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.